课题基金 / 基金详情

项目摘要

项目成果

Richard T Pomerantz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project summary DNA polymerase θ (Polθ) is a unique protein in higher eukaryotes because it contains a N-terminal superfamily 2 (SF2) helicase domain (Polθ-helicase) and a C-terminal A-family polymerase domain (Polθ- polymerase). Polθ is essential for the DNA double-strand break (DSB) repair pathway alternative end-joining (alt-EJ), also called microhomology-mediated end-joining (MMEJ). Polθ also promotes the proliferation of cancer cells defective in homology-directed repair (HDR) and confers resistance to chemotherapy agents. The structural and molecular basis of Polθ activity, however, remains unclear. For example, the activities of Polθ- helicase are poorly understood, and the structural basis for how Polθ-polymerase uniquely acts on single- strand DNA (ssDNA) overhangs and promotes MMEJ remains to be elucidated. Furthermore, how Polθ influences CRISPR-Cas9 genome editing remains poorly understood. In preliminary studies, we have discovered novel functions for Polθ-helicase including ssDNA annealing and DNA unwinding, and have identified optimal substrates for Polθ-polymerase MMEJ which will enable crystallographic studies of MMEJ. Lastly, we have discovered an unexpected and essential role for Polθ in CRISPR-Cas9 genome editing. We will utilize a collaborative approach among three labs (Pomerantz, Chen and Sfeir) to elucidate the structural and molecular basis of Polθ activity in DNA repair and genome editing by developing the following aims: 1. To investigate annealing, unwinding and anti-recombinase activities of Polθ; 2. To elucidate the structural basis of Polθ-polymerase dependent MMEJ; 3. To investigate Polθ involvement in CRISPR-Cas9 genome editing using ssDNA templates. In summary, these studies will provide new and significant insight into the structure and function of Polθ, and characterize an unexpected role for Polθ in CRISPR-Cas9 genome editing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure Based Design of Pol-theta inhibitors
  • 批准号:
    10323627
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2021
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Next-generation precision medicine for targeting recombination-deficient cancers
  • 批准号:
    9909705
  • 项目类别:
  • 资助金额:
    $29.9万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Mechanisms of RNA-DNA repair
  • 批准号:
    10336801
  • 项目类别:
  • 资助金额:
    $36.53万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
PolQ as a novel therapeutic target in AML
  • 批准号:
    10545175
  • 项目类别:
  • 资助金额:
    $52.39万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
海外基金